Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

NAFLD

Accurate quantification of hepatic fat—is it important?

Nature Reviews Gastroenterology & Hepatology volume 12, pages 126–127 (2015)Cite this article

Subjects

New ultrasonography and MRI techniques offer the promise of accessible and accurate quantification of hepatic steatosis. Application of these techniques to help define the natural history and severity of NAFLD is required before we can determine their clinical utility.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221–1231 (2002).

    Article  CAS  PubMed  Google Scholar 

  2. Lin, S. C. et al. Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique. Clin. Gastroenterol. Hepatol. http://dx.doi.org/10.1016/j.cgh.2014.11.027.

  3. Loomba, R. et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel MRI and MRE in a randomized trial (MOZART Trial). Hepatology http://dx.doi.org/10.1002/hep.27647.

  4. Targher, G., Day, C. P. & Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363, 1341–1350 (2010).

    Article  CAS  PubMed  Google Scholar 

  5. Noureddin, M. et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58, 1930–1940 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Korenblat, K. M., Fabbrini, E., Mohammed, B. S. & Klein, S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134, 1369–1375 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Lambert, J. E., Ramos-Roman, M. A., Browning, J. D. & Parks, E. J. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146, 726–735 (2014).

    Article  CAS  PubMed  Google Scholar 

  8. Sanyal, A. J. et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 54, 344–353 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Neuschwander-Tetri, B. A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52, 774–788 (2010).

    Article  PubMed  Google Scholar 

  10. Loomba, R. et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology 60, 1920–1928 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine and Pharmacology, The University of Western Australia, Queen Elizabeth II Medical Centre, Verdun Street, Nedlands, 6009, WA, Australia

    Leon A. Adams

Authors
  1. Leon A. Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leon A. Adams.

Ethics declarations

Competing interests

L.A.A. holds a commercialization agreement with Quest Diagnostics regarding Hepascore, a non-invasive predictor of fibrosis. L.A.A. is a co-holder of patents regarding Hepascore.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adams, L. Accurate quantification of hepatic fat—is it important?. Nat Rev Gastroenterol Hepatol 12, 126–127 (2015). https://doi.org/10.1038/nrgastro.2015.23

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2015.23

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing